K192524

Substantially Equivalent

Lumipulse G CA15-3

Applicant: Fujirebio Diagnostics,Inc.
Product code: MOI
Advisory panel: Immunology
Date received: 2019-09-13
Decision date: 2020-09-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Malvern, PA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.